ETR/LLY (ETR/LLY)

Deutsche Börse Xetra: ETR/LLY · EUR

€1,156

+7.35 (+0.6%)· Recorded snapshot

Market cap	1T
Revenue (ttm)	69.7B
Net income (ttm)	23.4B
EPS (ttm)	€26.8
P/E (trailing)	43.2x
P/E (forward)	33.6x
Dividend	€5.73 (0.50%)
Volume	1,049
Beta	0.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.7B
Net income (ttm): 23.4B
EPS (ttm): €26.8
P/E (trailing): 43.2x
P/E (forward): 33.6x
Market cap: 1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E33.6

P25 n/aP50 n/aP75 n/a

Trailing P/E43.2

P25 n/aP50 n/aP75 n/a

ROE102.3

P25 n/aP50 n/aP75 n/a

ROIC42.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ETR/LLY indicators

Market & fundamental data

Available fields

259

Groups with data

Currency

USD

Showing 259 of 259 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-29
Employees	50,000
Employees change	3,000
Employees growth	6.38%
Enterprise value	EUR 1.1T
Exchange	Deutsche Börse Xetra
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1876
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US5324571083
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	EUR 1T
Next earnings date	2026-10-29
Price	EUR 1,156.40
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	etr/LLY
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	52.78x
Average P/E ratio (3Y)	71.41x
Average P/E ratio (5Y)	62.99x
Earnings yield	2.32%
EV/Earnings	45.6x
EV/EBIT	29.99x
EV/EBITDA	28.34x
EV/FCF	66.96x
EV/Sales	14.91x
FCF / EV yield	1.49%
FCF yield	1.55%
Forward P/E	33.58x
Graham number	139.81596
Graham upside	-87.82%
Lynch fair value	EUR 654.31
Lynch upside	-43%
P/(FCF - SBC) ratio	66.79x
P/(OCF - SBC) ratio	42.71x
P/B ratio	34.58x
P/E ratio	43.19x
P/FCF ratio	64.41x
P/OCF ratio	41.72x
P/S ratio	14.71x
Price / tangible book value	169.31x
Price/EBITDA ratio	28.09x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	49.72%
EBITDA margin	52.35%
Effective tax rate	20.49%
FCF margin	22.24%
Gross margin	83.4%
Operating margin	49.72%
Pretax margin	42.17%
Profit margin	33.53%
Profit per employee	EUR 467,603
Profitable quarters	11
Profitable years	8
Revenue per employee	EUR 1.4M
ROA	20.36%
ROA (5Y)	13.51%
ROCE	41.89%
ROE	102.29%
ROE (5Y)	74.21%
ROIC	42.24%
ROIC (5Y)	35.51%
SBC / revenue	0.81%
Tax / revenue	8.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	94.8%
EPS growth (Q)	26.23%
EPS growth (QoQ)	-3.87%
EPS growth 10Y	29.08%
EPS growth 3Y	60.68%
EPS growth 5Y	34.97%
EPS growth quarters	11
EPS growth years	2
FCF growth	272.37%
FCF growth (Q)	458.06%
FCF growth (QoQ)	157.96%
FCF growth 3Y	69.77%
FCF growth 5Y	26.73%
Gross profit growth	50.96%
Gross profit growth (Q)	50.31%
Gross profit growth 3Y	42.51%
Gross profit growth 5Y	26.7%
Net income growth	93.56%
Net income growth (Q)	25.33%
Net income growth (QoQ)	-4.07%
Net income growth 3Y	60.19%
Net income growth 5Y	34.49%
Net income growth quarters	11
Net income growth years	2
OCF growth	156.73%
OCF growth (Q)	246.29%
OCF growth (QoQ)	100.45%
OCF growth 10Y	23.94%
OCF growth 3Y	65.09%
OCF growth 5Y	31.67%
Operating income growth	78.34%
Operating income growth (Q)	77.42%
Operating income growth 3Y	68.37%
Operating income growth 5Y	38.93%
Revenue growth	49.58%
Revenue growth (Q)	47.67%
Revenue growth (QoQ)	16.04%
Revenue growth 10Y	14.48%
Revenue growth 3Y	39.23%
Revenue growth 5Y	24.41%
Revenue growth quarters	13
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -8.7B
Depreciation and amortization	EUR 1.9B
EBIT	EUR 34.7B
EBITDA	EUR 36.5B
EPS	EUR 26.77
Financing cash flow	EUR 2.3B
Free cash flow	EUR 15.9B
Free cash flow minus SBC	EUR 15.4B
Gross profit	EUR 58.2B
Income taxes	EUR 6B
Investing cash flow	EUR -22B
Net borrowing	EUR 13.7B
Net cash flow	EUR 4.9B
Net income	EUR 23.4B
Operating cash flow minus SBC	EUR 24B
Operating income	EUR 34.7B
Revenue	EUR 69.7B
Stock-based compensation	EUR 568.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.55
Book value per share	EUR 33.26
Debt / EBITDA	1.31
Debt / equity	1.62
Debt / FCF	3.02
Goodwill	EUR 8B
Interest coverage	215.26
Long-term assets	EUR 66.4B
Long-term liabilities	EUR 52B
Net cash (debt)	EUR -39.5B
Net cash / market cap	-3.85%
Net debt / EBITDA	1.08
Net debt / equity	1.33
Net debt / FCF	2.48
Piotroski F-Score	7
Property, plant and equipment	EUR 26.3B
Shareholders' equity	EUR 29.7B
Tangible book value	EUR 6.1B
Tangible book value per share	EUR 6.79
Total assets	EUR 124.5B
Total cash	EUR 7.8B
Total debt	EUR 48.1B
Total liabilities	EUR 94.9B
WACC	6.45%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	EUR 58.1B
Current liabilities	EUR 42.9B
Current ratio	1.35
Inventory turnover	0.95
Net working capital	EUR 13.2B
Quick ratio	0.68
Working capital	EUR 14.8B
Working capital turnover	5.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.62%
Dividend growth	8.21%
Dividend growth (10Y)	12.15%
Dividend growth (3Y)	12.07%
Dividend growth (5Y)	15.74%
Dividend growth years	12
Dividend payment date	2026-09-10
Dividend payment years	29
Dividend payout frequency	Quarterly
Dividend per share	EUR 5.73
Dividend yield	0.5%
Ex-dividend date	2026-08-14
Last dividend	EUR 1.50
Payout ratio	21.66%
Shareholder yield	1.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	1,543.31%
10Y return CAGR	34.4%
10Y total return	1,822.13%
150-day SMA	EUR 973.88
15Y price change	4,243.29%
15Y return CAGR	31.46%
15Y total return	5,951.38%
1D price change	0.64%
1M price change	13.2%
1M total return	13.2%
1W price change	0.12%
1W total return	0.12%
1Y price change	63.91%
1Y return CAGR	65%
1Y total return	64.94%
20-day SMA	EUR 1,092.61
200-day SMA	EUR 945.90
3M price change	9.78%
3M total return	9.93%
3Y price change	117.37%
3Y return CAGR	30.43%
3Y total return	121.91%
50-day SMA	EUR 1,046.37
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 1,175.80
52-week high date	2026-10-22
52-week low	EUR 697.70
52-week low date	2025-10-30
5Y price change	432.17%
5Y return CAGR	40.99%
5Y total return	456.94%
6M price change	54.02%
6M total return	54.51%
All-time high	EUR 1,175.80
All-time high date	2026-10-22
All-time low	EUR 21.58
All-time low date	2008-10-10
Average true range (ATR)	EUR 30.78
Average volume	1.4K
Beta (5Y)	0.45
Change from 52-week high	-1.65%
Change from 52-week low	65.75%
Change from all-time high	-1.65%
Change from all-time low	5,258.67%
Change from open	0.43%
Day's gap	0.21%
Dollar volume	EUR 1.2M
High price	EUR 1,166.20
Low price	EUR 1,137.20
Monthly RSI	70.08
Open price	EUR 1,151.40
Position in 52-week range	66.21%
Previous close	EUR 1,149.00
Price vs 150-day SMA	18.74%
Price vs 20-day SMA	5.84%
Price vs 200-day SMA	22.25%
Price vs 50-day SMA	10.52%
Relative volume	0.74
RSI	62.6
Sharpe ratio	1.49
Sharpe ratio (3Y)	0.8
Sharpe ratio (5Y)	1.03
Sortino ratio	2.52
Sortino ratio (3Y)	1.33
Sortino ratio (5Y)	1.75
Volume	1K
Weekly RSI	68.08
YTD price change	26.16%
YTD total return	26.77%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	888.9M
Shares change (QoQ)	-0.25%
Shares change (YoY)	-0.62%
Shares held by insiders	0.17%
Shares held by institutions	89.36%
Short ratio	2.8 days

Deeper analysis on ETR/LLY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/LLY report

Is a complete ETR/LLY research report available?

No complete published report is available for etr/LLY (ETR/LLY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/LLY (ETR/LLY)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/LLY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/LLY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/LLY

Frequently asked questions